Mid-afternoon market update: Dow falls 140 points; EXFO shares spike higher
|Toward the end of trading Monday, the Dow traded down 0.40% to 34,616 while the NASDAQ rose 0.49% to 13,882.39. The S&P also fell, dropping 0.10% to 4,225.78.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 33,363,340 cases with around 597,630 deaths. India confirmed a total of at least 28,909,970 cases and 349,180 deaths, while Brazil reported over 16,947,060 COVID-19 cases with 473,400 deaths. In total, there were at least 173,337,740 cases of COVID-19 worldwide with more than 3,730,060 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Real estate shares climbed 1.2% on Monday. Meanwhile, top gainers in the sector included QTS Realty Trust, Inc. QTS 21.1%, up 21%, and Nam Tai Property Inc. NTP 16.43%, up 19%.
In trading on Monday, materials shares fell 1.4%.
Top Headline
G-III Apparel Group, Ltd. GIII 9.26% reported better-than-expected results for its first quarter.
G-III Apparel reported quarterly earnings of $0.53 per share, beating analysts’ estimates of $0.15 per share. The company’s quarterly sales came in at $519.90 million, versus expectations of $462.03 million.
G-III Apparel said it expects Q2 earnings of $0.03 to $0.13 per share on sales of $470 million. The company also sees FY22 adjusted earnings of $2.60 to $2.78 per share on sales of $2.53 billion.
Equities Trading UP
U.S. Concrete, Inc. USCR 29.2% shares shot up 29% to $73.72. Vulcan announced plans to acquire U.S. Concrete for $74 per share in cash.
Shares of EXFO Inc. EXFO 60.27% got a boost, shooting 61% to $5.95 after the company announced a going-private transaction by its found and majority shareholder, Germain Lamonde.
Liminal BioSciences Inc. LMNL 27.36% shares were also up, gaining 29% to $5.20. Liminal BioSciences reported the FDA approval for its Biologics License Application for Ryplazim.
Equities Trading DOWN
MoSys, Inc. MOSY 20.76% shares tumbled 19% to $7.36 after the company announced a $13 million registered direct offering priced at $7.15 per share.
Shares of Newtek Business Services Corp. NEWT 8.31% were down 9% to $35.16. Compass Point downgraded Newtek Business Services from Buy to Neutral and raised the price target from $33 to $38.
Fuel Tech, Inc. FTEK 14.33% was down, falling 14% to $2.5127 after surging over 36% on Friday. The company, last month, reported quarterly results.
Commodities
In commodity news, oil traded down 0.6% to $69.23, while gold traded up 0.5% to $1,901.80.
Silver traded up 0.6% Monday to $28.065 while copper fell 0.3% to $4.5175.
Euro zone
European shares closed mostly higher today. The eurozone’s STOXX 600 gained 0.22%, the Spanish Ibex Index rose 0.83% and the German DAX 30 declined 0.10%. Meanwhile, the London’s FTSE 100 gained 0.12%, French CAC 40 rose 0.43% and Italy’s FTSE MIB gained 0.99%.
UK’s Halifax house price index increased 9.5% year-over-year in May. Spain's industrial production surged 48.2% year-over-year in April. Factory orders in Germany declined 0.2% in April.
Economics
US consumer credit rose by $18.61 billion in April versus a revised $18.6 billion increase in the prior month.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.